19:14 IST
BSE
Annual General Meeting
Torrent Pharmaceuticals Annual General Meeting
Shareholders approved the appointment of Ms. Shanti Ekambaram as an Independent Director of Torrent Pharmaceuticals via Postal Ballot.
Torrent Pharmaceuticals Ltd
- Share price
- ₹4,716.20
- Market cap
- ₹1,79,389 Cr
- Revenue (annual)
- ₹13,980 Cr
- Net profit (annual)
- ₹2,163 Cr
- P/E (TTM)
- 82.2×Sector 47.4×
- Promoter holding
- 60.78%-7.53% QoQ
- FII holding
- 17.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 5Debt & Borrowing 4Board Meeting Date 4Merger & Restructuring 3Financial Results 3Earnings Call 3Annual General Meeting 3Acquisition 2Regulatory Approval 1Management Change 1Fund Raise 1Dividend 1Annual Report 1Adverse Business Impact 1
Time
3 announcements with these filters
17:43 IST
NSE
Annual General Meeting
Torrent Pharmaceuticals Annual General Meeting
Torrent Pharmaceuticals issued a Postal Ballot notice to shareholders for the appointment of Shanti Ekambaram as an Independent Director. Voting concludes on September 6, 2026.
19:10 IST
NSE
Annual General Meeting
Torrent Pharmaceuticals Annual General Meeting
Torrent Pharmaceuticals scheduled its 53rd Annual General Meeting for June 23, 2026. Key agenda items include adopting FY26 financial statements, confirming dividends, and re-appointing Director Samir Mehta.